108787 ⎘
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Animal cells or tissues; Human cells or tissues; Vertebrate cells; Cells of skeletal and connective tissues; Mesenchyme Cardiomyocytes; Heart cells
Methods and products for transfecting cells
#302REAGENTS AND METHODS WITH WNT AGONISTS AND BIOACTIVE LIPIDS FOR GENERATING AND EXPANDING CARDIOMYOCYTES
#303METHODS AND COMPOSITIONS FOR PREPARING CARDIOMYOCYTES FROM STEM CELLS AND USE THEREOF
#304Mold and Method for Preparing a Hollow 3D Cell Tissue Structure
#305METHODS AND COMPOSITIONS FOR MRNA-BASED MODULATION AND DETECTION OF CELL PHENOTYPES
#306Mature Cardiomyocyte Compositions
#307PREPARATION AND APPLICATIONS OF BIOCOMPATIBLE CONDUCTIVE 3D HYDROGELS BASED ON CELLULOSE NANOFIBRILS FOR DIAGNOSTICS AND INTERVENTION OF NEURODEGENERATIVE AND CARDIAC DISEASES
#308METHODS AND COMPOSITIONS FOR DETECTING AND PROMOTING CARDIOLIPIN REMODELING AND CARDIOMYOCYTE MATURATION AND RELATED METHODS OF TREATING MITOCHONDRIAL DYSFUNCTION
#309METHODS OF FORMING CARDIOMYOCYES
#310Solubilization of antigen components for removal from tissues
#311MEMBRANE AND METHOD FOR CULTURE AND DIFFERENTIATION OF CELLS
#312COMPOSITIONS AND METHODS FOR CORRECTING DYSTROPHIN MUTATIONS IN HUMAN CARDIOMYOCYTES
#313Cardiomyocytes derived from pluripotent mammalian stem cells
#314METHOD FOR PRODUCING CELL
#315Blood type O Rh-hypo-immunogenic pluripotent cells
#316Method for producing cardiomyocytes
#317METHOD OF FABRICATING CELL ARRAYS AND USES THEREOF
#318Methods for making and using sinoatrial node-like pacemaker cardiomyocytes and ventricular-like cardiomyocytes
#319Direct reprogramming of cells to cardiac myocyte fate
#320Compounds for use in the elimination of pluripotent stem cells
#321Methods for cardiac tissue repair with compositions comprising CTGF
#322Cardiogenic mesoderm formation regulators
#323Method for freezing aggregates of pluripotent stem cell-derived cardiomyocytes
#324Methods and products for transfecting cells
#325MicroRNA-294 and Lin28A as a driver of cardiac tissue proliferation in response to pathological injury
#326Process for generation, identification and isolation of human pluripotent stem cell-derived cardiomyocytes and cardiomyocyte subpopulations
#327CELL CULTURE CONTAINER, METHOD FOR ACQUIRING CELLS, AND METHOD FOR CULTURING CELLS
#328ENGINEERED CARDIOMYOCYTES AND USES THREOF
#329Methods and products for transfecting cells
#330Methods and products for transfecting cells
#331Organoid and method for producing same
#332Systems and Methods for Automated Processing of Signals from Cardiomyocytes in an Unbiased Manner
#333Device and method for producing and purifying exosomes
#334Genetic markers for engraftment of human cardiac ventricular progenitor cells
#335Methods for the maturation of cardiomyocytes on amniotic fluid cell-derived ECM, cellular constructs, and uses for cardiotoxicity and proarrhythmic screening of drug compounds
#336USE OF LIFR OR FGFR3 AS A CELL SURFACE MARKER FOR ISOLATING HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS
#337Identification of subpopulations of cardiomyocytes
#338Methods for obtaining cardiomyogenic precursor cells
#339Methods for Enriching Pluripotent Stem Cell-Derived Cardiomyocyte Progenitor Cells and Cardiomyocyte Cells based on SIRPA Expression
#340A Method of Preparing a Pluripotent Stem Cell Suitable for Differentiating into a Cardiomyocyte
#341Method for producing engineered heart muscle (EHM)
#342Human pluripotent stem cell derived endocardial endothelium
#343COMPOSITIONS AND METHODS FOR DETECTING CARDIOTOXICITY
#344Adaptive electrode arrangement and method
#345COMPOSITIONS AND METHODS FOR ENHANCING MATURATION STATES OF HEALTHY AND DISEASED CARDIOMYOCYTES
#346DECELLULARIZATION AND RECELLULARIZATION OF ORGANS AND TISSUES
#347CELL REPROGRAMMING TO CARDIOMYOCYTES
#348In vivo method for differentiating human pluripotent stem cells into atrial cardiomyocytes
#349Flexible device and its application for bio-cell in-vitro electrical and mechanical stimulation and characterization
#350METHODS FOR IDENTIFYING AND ISOLATING CARDIAC STEM CELLS AND METHODS FOR MAKING AND USING THEM
#351MITOCHONDRIAL TRANSPLANTATION TO ALTER ENERGY METABOLISM
#352Recombinant cardiomyocytes and cardiomyocyte cell lines expressing hERG
#353THE USE OF MECHANICAL (ACOUSTIC/SUBSONIC) VIBRATION FOR A NOVEL PARADIGM IN REGENERATIVE MEDICINE AND HUMAN WELL BEING
#354CARDIAC STEM CELLS AND METHODS OF IDENTIFYING AND USING THE SAME
#355METHODS FOR REPROGRAMMING CELLS AND USES THEREOF
#356Methods and products for transfecting cells
#357Multiloop engineered heart muscle tissue
#358Methods for isolating human cardiac ventricular progenitor cells
#359Method for the isolation of subpopulations of cardiac progenitor cells and related uses in the medical field
#360Method of inducing cardiomyocytes proliferation and treating heart diseases
#361Method for in vitro detection of the proarrhythmogenic risk of a drug candidate on human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM)
#362Preparation method of human-derived cardiac stem cell spheroid and use thereof
#363Prevention and Treatment of Teratoma Formation in Stem Cell-Based Therapies Using Alternating Electric Fields
#364METHOD FOR PREPARING DIFFERENTIATION-INDUCED CELLS
#365Method for increasing the proportion of desired cells from induced pluripotent stem cells
#366OMENTUM BASED SCAFFOLD AND DELIVERY SYSTEM
#367Bone marrow derived neurokinin-1 receptor positive (NK1R+) mesenchymal stem cells for therapeutic applications
#368Gene-therapy vectors for treating cardiomyopathy
#369MATERIALS AND METHODS FOR TREATMENT OF MEROSIN-DEFICIENT COGENITAL MUSCULAR DYSTROPHY (MDCMD) AND OTHER LAMININ, ALPHA 2 (LAMA2) GENE RELATED CONDITIONS OR DISORDERS
#370Methods and systems for functional maturation of iPSC and ESC derived cardiomyocytes
#371SYSTEMS AND METHODS EMPLOYING IMMORTALIZED INDUCED PLURIPOTENT STEM CELLS AS A PLATFORM FOR UNLIMITED LIFETIME GENETIC ANALYSIS
#372Methods and products for transfection
#373ENGINEERED PLATFORM FOR CONNECTED MICROPATTERNED CARDIAC TISSUES
#374CONDITIONALLY IMMORTALIZED CELLS AND METHODS FOR THEIR PREPARATION
#375Exosomes and micro-ribonucleic acids for tissue regeneration
#376CARDIAC TISSUE MODELS AND METHODS OF USE THEREOF
#377Additive manufacturing of functional myocardial tissue
#378Drug discovery platform for Duchenne cardiomyopathy
#379Sub-pascal unidirectional flow valves
#380Dominant active yap, a hippo effector, induces chromatin accessibility and cardiomyocyte renewal
#381Methods of Reducing Teratoma Formation During Allogeneic Stem Cell Therapy
#382Myocyte-derived flow assist device: extravasal sheaths of rhythmically contracting myocytes aiding flow of biological fluids
#383Method for inducing trans-differentiation of cardiomyocytes based on exosome
#384Methods and products for transfecting cells
#385METHOD, DEVICE AND KIT FOR DETERMINING CARDIAC CONDUCTION
#386CARDIAC MYOFIBRIL INDUCTION
#387Reprogramming of cells to a new fate
#388CELLS WITH IMPROVED INWARD RECTIFIER CURRENT
#389APPARATUS AND METHODS FOR IN VITRO PRECLINICAL HUMAN TRIALS
#390HUMAN CARDIAC TISSUE CONSTRUCT, RELATED METHODS AND USES
#391CARDIAC PROGENITOR CELLS HAVING ENHANCED p53 EXPRESSION AND USES THEREOF
#392C-KIT-POSITIVE BONE MARROW CELLS AND USES THEREOF
#393DECELLULARIZATION AND RECELLULARIZATION OF SOLID ORGANS
#394OPTIMIZED STRATEGY FOR EXON SKIPPING MODIFICATIONS USING CRISPR/CAS9 WITH TRIPLE GUIDE SEQUENCES
#395GENERATING ATRIAL AND VENTRICULAR CARDIOMYOCYTE LINEAGES FROM HUMAN PLURIPOTENT STEM CELLS
#396METHODS FOR ENRICHING PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTE PROGENITOR CELLS AND CARDIOMYOCYTE CELLS BASED ON SIRPA EXPRESSION
#397MEDIA AND METHODS FOR EXPANSION OF PLURIPOTENT STEM CELLS
#398Engineered platform to generate 3D cardiac tissues
#399A METHOD TO DIRECT DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO FUNCTIONAL HEART MUSCLE
#400UNDIFFERENTIATED STEM CELL-REMOVING AGENT, AND METHOD FOR REMOVING UNDIFFERENTIATED STEM CELLS
#401Messenger RNA based expression of opsins and reporter proteins for electrophysiologic characterization of in vitro neurons and cardiomyocytes
#402Methods for selective inhibition of pluripotent stem cells
#403Derivation and self-renewal of ISI1+ cells and uses thereof
#404Encapsulation and cardiac differentiation of hiPSCs in 3D PEG-fibrinogen hydrogels
#405Method for inducing pluripotent stem cells to differentiate into somatic cells
#406CAMK2D antisense oligonucleotides and uses thereof
#407PRESERVATIVE SOLUTION FOR LIVE CELLS OR COMPOSITION CONTAINING LIVE CELLS
#408Methods and products for transfecting cells
#409MicroRNAs for cardiac regeneration through induction of cardiac myocyte proliferation
#410Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
#411Methods for determining drug effects on a mature cardiomyocyte
#412Methods and products for transfection
#413Methods and Compositions for the Clinical Derivation of an Allogenic Cell and Therapeutic Uses
#414Method for producing somatic cell, somatic cell, and composition
#415Compositions and methods to derive mesodermal lineage cells and mixed tissue organoids from embryonic stem cells
#416Method for Culturing Pluripotent Stem Cells on Specific Laminin
#417Cell-specific expression of modRNA
#418Cardiomyocyte maturation
#419Biomolecular patterning of three dimensional tissue scaffolds
#420CARDIAC MICROTISSUE AND USES THEREOF
#421Compositions of Ascorbic Acid and Bone Morphogenetic Protein 4 (BMP-4) for Cell Growth and Uses Related Thereto
#422SYSTEMS AND METHODS FOR MODELING DISEASE AND ASSESSING ADVERSE SIDE EFFECTS OF THERAPEUTICS THEREFOR
#423Method for preparing pluripotent stem cell-derived cardiomyocyte population
#424STEM CELL LINE FOR TREATMENT OF VARIOUS MEDICAL CONDITIONS
#425Engineered Stem Cell Therapy for Cardiac Repair
#426Uses of epithelial-to-mesenchymal inhibitors in generating pacemaker cells
#427Muscle cell patches and uses therefor
#428Automated system for high-throughput all-optical dynamic electrophysiology
#429Methods of Producing Specialized Cardio-Like Cells from Stem Cells
#430DIFFERENTIATION OF PLURIPOTENT STEM CELLS AND CARDIAC PROGENITOR CELLS INTO STRIATED CARDIOMYOCYTE FIBERS USING LAMININS LN-511, LN-521 AND LN-221
#431ENGINEERING MULTILEVEL CELL SHEET-DERIVED BLOOD VESSELS
#432Methods and compositions for generating pacemaker cells
#433Device, system and kit for measuring tension of sheet-like tissue containing cardiomyocytes
#434GENERATION OF ADULT-LIKE HEART MUSCLE FROM HUMAN PLURIPOTENT STEM CELLS
#435Derivation and Self-Renewal of Multipotent Cells and Uses Thereof
#436Cells for Therapy of the Heart
#437CELL CULTURE MEDIUM AND CULTURE MEDIUM SUPPLEMENT
#438Methods for reprogramming cells and uses thereof
#439Methods for epicardial differentiation of human pluripotent stem cells
#440METHOD FOR PRODUCING CARDIAC PRECURSOR CELL AND MYOCARDIAL CELL FROM PLURIPOTENT STEM CELL
#441METHOD FOR DIRECTLY PRODUCING CARDIAC PRECURSOR CELL OR MYOCARDIAL CELL FROM FIBROBLAST
#442Composition comprising porous silica particles carrying a cell fate modulating factor
#443Multiloop engineered heart muscle tissue
#444Use of Neuropilin-1 (NRP1) as a cell surface marker for isolating human cardiac ventricular progenitor cells
#445METHODS FOR GENERATING CARDIOMYOCYTES
#446ENERGETIC THREE-DIMENSIONAL ARTIFICIAL CARDIAC PATCH AND USES THEREOF
#447REPROGRAMMING CARDIOMYOCYTES WITH ONE TRANSCRIPTION FACTOR
#448Small molecule compound composition that efficiently induces differentiation of human pluripotent stem cells into myocardial cells
#449Methods for producing cardiomyocyte cells
#450Generation of Expandable Cardiovascular Progenitor Cells
#451SYSTEMS AND METHODS FOR CARDIOMYOCYTE PACING
#452METHOD TO DIRECT DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO FUNCTIONAL HEART MUSCLE
#453Electrospun PNIPAAm/PCL fiber mats for aligned cell sheets
#454Cell medium formulation for cell stabilization
#455Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
#456POLYMERIC FIBER-SCAFFOLDED ENGINEERED TISSUES AND USES THEREOF
#457Cardiac cell culture material
#458Human cardiovascular progenitor cells
#459DIFFERENTIATION OF PLURIPOTENT STEM CELLS AND CARDIAC PROGENITOR CELLS INTO STRIATED CARDIOMYOCYTE FIBERS USING LAMININS LN-511, LN-521 AND LN-221
#460Method for differentiating induced pluripotent stem cells, which are prepared from endocardium-derived adult stem cells, into cardiovascular cells, and use thereof
#461Contractile function measuring devices, systems, and methods of use thereof
#4623-DIMENSIONAL CARDIAC FIBROBLAST DERIVED EXTRACELLULAR MATRIX
#463Direct reprogramming of cells to cardiac myocyte fate
#464LABEL-FREE IDENTIFICATION OF STEM CELL-DIFFERENTIATED CELLS
#465Methods and products for transfection
#466Methods for Cardiac Differentiation of Human Induced Pluripotent Stem Cells
#467DIRECTED DIFFERENTIATION OF PLURIPOTENT STEM CELLS BY BACTERIAL INJECTION OF TALEN PROTEINS
#468Method of inducing cardiomyocytes proliferation and treating heart diseases
#469Preparation and applications of biocompatible conductive inks based on cellulose nanofibrils for 3D printing of conductive biomedical devices and for use as models for study of neurodegenerative disorders and connection between brain/neurons and communication or other electronic devices
#470Apicidin-containing composition for inducing differentiation of mesenchymal stem cells into cardiac-committed cells
#471MICROVESICLE AND STEM CELL COMPOSITIONS FOR THERAPEUTIC APPLICATIONS
#472SPONTANEOUSLY BEATING CARDIAC ORGANOID CONSTRUCTS AND INTEGRATED BODY-ON-CHIP APPARATUS CONTAINING THE SAME
#473Induced pacemaker and Purkinje cells from adult stem cells
#474In vitro method of differentiating a human pluripotent stem cell population into a cardiomyocyte cell population
#475Method for reducing pluripotent stem cells, method for producing cell population having reduced pluripotent stem cells
#476Methods and products for transfection
#477Compositions and methods for cardiac tissue repair
#478Cellular seeding and co-culture of a three dimensional fibroblast construct
#479Silylated biomolecule-based hydrogel for culturing cardiomyocytes and stem cells, and use of the hydrogel thereof for treating heart failure
#480METHOD OF DIFFERENTIATING MESENCHYMAL STEM CELLS INTO CARDIOMYOCYTES
#481CELL CULTURE DEVICE
#482Cardiomyocyte-Specific Biological Markers and Uses Thereof
#483Cardiac stem cells and methods of identifying and using the same
#484Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy
#485Solubilization of antigen components for removal from tissues
#486Method for culturing animal cell composition, method for producing animal cell composition using same, and animal cell composition
#487METHOD FOR CRYOPRESERVATION OF CARDIOCYTES DERIVED FROM PLURIPOTENT STEM CELLS OR MESENCHYMAL STEM CELLS DERIVED FROM ADIPOSE TISSUE OR BONE MARROW
#488Methods for accelerated and enhanced cardiac differentiation of IPS cells by electrical stimulation
#489Methods for isolating human cardiac ventricular progenitor cells
#490Methods and devices for producing trabecular fibers
#491Artificial transcription factors and uses thereof
#492Method for producing myocardial cells using synthetic peptide
#493DIRECTED DIFFERENTIATION OF PLURIPOTENT STEM CELLS BY BACTERIAL INJECTION OF TALEN PROTEINS
#494Vectors and methods for regenerative therapy
#495Methods and products for transfection
#496Exosomes and micro-ribonucleic acids for tissue regeneration
#497Method of making cardiomyocytes from human pluripotent cells
#498Method of differentiating human pluripotent cells into cardiac fibroblasts
#499MULTIPOTENT STEM CELLS AND USES THEREOF
#500MULTIPOTENT STEM CELLS AND USES THEREOF
#501METHODS FOR ENHANCING MATURATION OF CARDIOMYOCYTES
#502Transcription factor-based generation of pacemaker cells and methods of using same
#503p63 inactivation for the treatment of heart failure
#504Multipotent stem cells and uses thereof
#505Treatment of heart disease
#506CONTRACTILE CELLULAR CONSTRUCT FOR CELL CULTURE
#507Two stage cellularization strategy for the fabrication of bioartificial hearts
#508Assays for measuring cardiotoxicity
#509Therapeutic miRNAs for treating heart and skeletal muscle diseases
#510Producing mesodermal cell types and methods of using the same
#511Methods for making and using sinoatrial node-like pacemaker cardiomyocytes and ventricular-like cardiomyocytes
#512OMENTUM BASED SCAFFOLD AND DELIVERY SYSTEM
#513Cardiac tissues containing semiconductor nanomaterials and methods of preparing and using the same
#514Method for sorting cardiomyocytes
#515Methods for non-invasive profiling of stem cell differentiation
#516PROCESSES FOR PRODUCING STABLE EXOSOME FORMULATIONS
#517MATURE CARDIAC MUSCLE CELL MARKER
#518Extracellular Matrix Scaffolds
#519Serum-free and xenogen-free human cardiac explant-derived stem cells and uses and methods for the production thereof
#520Cardiomyocyte marker
#521DIFFERENTIATION-INDUCED CELL POPULATION FROM WHICH UNDIFFERENTIATED CELLS HAVE BEEN REMOVED, USE OF SAME, AND METHOD FOR PRODUCING SAME
#522MULTIPOTENT STEM CELLS AND USES THEREOF
#523HIGHLY ELASTIC AND MOLDABLE POLYESTER BIOMATERIAL FOR CARDIAC TISSUE ENGINEERING APPLICATIONS
#524Methods and products for transfection
#525Three-dimensional electronic scaffold for cardiac applications
#526CARDIAC PLATFORM FOR ELECTRICAL RECORDING OF ELECTROPHYSIOLOGY AND CONTRACTILITY OF CARDIAC TISSUES
#527Cardiomyocyte maturation platform
#528Myocardial cell sheet
#529Genetic markers for engraftment of human cardiac ventricular progenitor cells
#530Human pluripotent stem cell derived endocardial endothelium
#531Cardiac progenitor cells and methods of use therefor
#532TISSUE-SPECIFIC DIFFERENTIATION MATRICES AND USES THEREOF
#533Cardiomyocyte production
#534Reversible stencils for fabricating micro-tissues
#535Encapsulation and cardiac differentiation of hiPSCs in 3D PEG-fibrinogen hydrogels
#536METHODS USING REPROGRAMMED CELLS FOR REGENERATIVE, RESTORATIVE, AND REJUVENATIVE THERAPIES
#537Induced pacemaker and Purkinje cells from adult stem cells
#538Apparatus and method for culturing cells and tissue
#5392,4,5-tri-substituted azole-based casein kinase 1 inhibitors as inducers for cardiomyogenesis
#540Reprogramming of cells to a new fate
#541Cardiomyocyte maturation
#542Cell surface signature for processing cardiomyocyte subsets from heterogeneous cell samples
#543Method for inducing cardiac differentiation of pluripotent stem cell with low-molecular compounds
#544Polypeptide hydrogels and uses related thereto
#545CARDIAC CELL CULTURE MATERIAL
#546Method for producing sinoatrial node cells (pacemaker cells) from stem cells, and use of the produced sinoatrial node cells
#547Methods for reprogramming cells and uses thereof
#548Methods for reprogramming cells and uses thereof
#549MicroRNA induction of cardiac regeneration
#550Methods and products for transfection
#551Cell-based electromechanical biocomputing
#552CD82-positive cardiac progenitor cells
#553Injectable cell-laden biohybrid hydrogels for cardiac regeneration and related applications
#554Cardiomyocytes From Induced Pluripotent Stem Cells From Patients and Methods of Use Thereof
#555Methods for producing cardiomyocyte cells
#556Method for monitoring differentiation into cardiac muscle cells
#557Methods for epicardial differentiation of human pluripotent stem cells
#558IN-VITRO BIOREACTOR
#559Vascularized in vitro perfusion devices, methods of fabricating, and applications thereof
#560Engineered adult-like human heart tissue
#561Generating cardiac progenitor cells from pluripotent stem cells using isoxazole or isoxazole like compounds
#562Purification of cell mixtures using molecular beacons targeting cell specific RNA
#563Generation of cardiomyocytes from human pluripotent stem cells
#564Surface energy directed cell self assembly
#565ENRICHED POPULATIONS OF CARDIOMYOCYTE LINEAGE CELLS FROM PLURIPOTENT STEM CELLS
#566Cardiac, mesenchymal and endothelial progenitor cell (CPC) chimeras and methods for making and using them
#567CULTURE MEDIUM FOR STEM CELL DIFFERENTIATION
#568Methods for selective inhibition of pluripotent stem cells
#569Methods and products for transfecting cells
#570Cardiac myofibril induction
#571Bioactive implant for myocardial regeneration and ventricular chamber restoration
#572METHOD FOR IDENTIFYING AND SELECTING CARDIOMYOCYTES
#573Therapeutic miRNAs for treating heart and skeletal muscle diseases
#574Methods and products for transfecting cells
#575PATTERNED CARDIOMYOCYTE CULTURE ON MICROELECTRODE ARRAY
#576METHOD FOR DETERMINING THE CARDIO-GENERATIVE POTENTIAL OF MAMMALIAN CELLS
#577Pharmaceutical composition for the treatment of heart diseases
#578Directed cardiomyocyte differentiation and ventricular specification of stem cells
#579Electronic scaffold and uses thereof
#580Cardiotoxicity screening methods
#581Reprogramming of cells to a new fate
#582METHODS FOR MODULATING AND ASSAYING m6A IN STEM CELL POPULATIONS
#583Reprogramming fibroblasts into cardiomyocytes
#584Muscle cell patches and uses therefor
#585Cardiac neural crest cells and methods of use thereof
#586CARDIAC STEM CELLS AND USES OF SAME IN CARDIAC REPAIR
#587MULTIPOTENT STEM CELLS AND USES THEREOF
#588CO-RELEASING COMPOUNDS & FORMULATIONS THEREOF USEFUL FOR INDUCING MITOCHONDRIAL BIOGENESIS AND TISSUE REPAIR
#589Catheter for cell infusion and method of pressure regulation
#590Image analysis device, image analysis method, image analysis program, cell manufacturing method, cell culturing method, and cell manufacturing device
#591CHEMICALLY DEFINED CULTURE MEDIUM FOR STEM CELL MAINTENANCE AND DIFFERENTIATION
#5923-dimensional cardiac fibroblast derived extracellular matrix
#593Treatment of heart disease
#594Methods, devices, and systems for treating pericardial tissue
#595Method to direct differentiation of pluripotent stem cells into functional heart muscle
#596Methods and compositions for generating epicardium cells
#597Assay for drug discovery based on in vitro differentiated cells
#598Methods for accelerated and enhanced cardiac differentiation of IPS cells by electrical stimulation
#599Method for producing engineered heart muscle (EHM)
#600Methods for Inducing Cardiomyogenesis